Literature DB >> 7538720

Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells.

T Yamada1, K Miyazaki, N Koshikawa, M Takahashi, H Akatsu, T Yamamoto.   

Abstract

Gelatinase A is an enzyme capable of cleaving soluble beta-amyloid protein (beta AP), and may function as an alpha-secretase to produce secretory forms of amyloid precursor protein. We examined gelatinase A immunoreactivity in the brains and posterior roots of neurologically normal, lacunar stroke, Alzheimer disease (AD), amyotrophic lateral sclerosis, progressive supranuclear palsy and myasthenia gravis cases. The gelatinase A antibody stained only microglial cells in the white matter in all the brain tissues. In AD brain, the reactive microglia located in the center of classical senile plaques, as well as in other microglial cells in the gray matter, showed no immunoreactivity. Gelatinase A in white matter microglial cells may play a role in preventing local deposition of beta AP. In the posterior root, Schwann cells had positive immunoreactivity. As with other metalloproteases, gelatinase A in Schwann cells may play an antiproliferative role.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538720     DOI: 10.1007/bf00309334

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR.

Authors:  T E Golde; S Estus; M Usiak; L H Younkin; S G Younkin
Journal:  Neuron       Date:  1990-02       Impact factor: 17.173

2.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

Authors:  P Cras; M Kawai; S Siedlak; P Mulvihill; P Gambetti; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

5.  Secretory form of beta-amyloid precursor protein is much abundantly contained in the cerebral white matter in human brain.

Authors:  T Tokuda; K Tanaka; F Kametani; S Ikeda; N Yanagisawa
Journal:  Neurosci Lett       Date:  1994-07-04       Impact factor: 3.046

6.  Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues.

Authors:  T Yamada; H Tsubouchi; Y Daikuhara; M Prat; P M Comoglio; P L McGeer; E G McGeer
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

7.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.

Authors:  T Salo; L A Liotta; K Tryggvason
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

8.  Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion.

Authors:  C Haass; A Y Hung; D J Selkoe
Journal:  J Neurosci       Date:  1991-12       Impact factor: 6.167

9.  Involvement of a metalloprotease in low-affinity nerve growth factor receptor truncation: inhibition of truncation in vitro and in vivo.

Authors:  P S DiStefano; D M Chelsea; C M Schick; J F McKelvy
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

10.  Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation.

Authors:  D Muir; M Manthorpe
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  13 in total

1.  Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.

Authors:  B O Evert; I R Vogt; C Kindermann; L Ozimek; R A de Vos; E R Brunt; I Schmitt; T Klockgether; U Wüllner
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

2.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

3.  Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.

Authors:  Mei-Chen Liao; William E Van Nostrand
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

4.  Degradation of amyloid beta protein by purified myelin basic protein.

Authors:  Mei-Chen Liao; Mahiuddin Ahmed; Steven O Smith; William E Van Nostrand
Journal:  J Biol Chem       Date:  2009-08-19       Impact factor: 5.157

5.  Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation.

Authors:  Milena Pinto; Alicia M Pickrell; Hirokazu Fukui; Carlos T Moraes
Journal:  Neurobiol Aging       Date:  2013-05-21       Impact factor: 4.673

6.  Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan.

Authors:  J Zuo; T A Ferguson; Y J Hernandez; W G Stetler-Stevenson; D Muir
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

7.  White matter microglia produce membrane-type matrix metalloprotease, an activator of gelatinase A, in human brain tissues.

Authors:  T Yamada; Y Yoshiyama; H Sato; M Seiki; A Shinagawa; M Takahashi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 8.  Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.

Authors:  Maruti J Dhanavade; Kailas D Sonawane
Journal:  3 Biotech       Date:  2020-05-11       Impact factor: 2.406

9.  beta-Amyloid degradation and Alzheimer's disease.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  J Biomed Biotechnol       Date:  2006

Review 10.  Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.

Authors:  D Farfara; V Lifshitz; D Frenkel
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.